Search tips
Search criteria 


Logo of mjafiGuide for AuthorsAbout this journalExplore this journalMedical Journal, Armed Forces India
Med J Armed Forces India. 2000 January; 56(1): 37–39.
Published online 2017 June 8. doi:  10.1016/S0377-1237(17)30088-6
PMCID: PMC5531953



60 cases of mid-trimester pregnancy were terminated using endocervical PGE2 gel (for achieving cervical priming) followed by serial intramuscular injections of carboprost. In this prospective study, 56 cases were multiparae with gestational age varying between 15-22 weeks. The induction-abortion-interval was 8.4h ± 0.8h with a success rate of 100%. The incidence of incomplete abortion was 5% and check curettage was performed in 16.6% cases. Gastrointestinal side effects were common. Vomiting occurred in 42% cases and diarrhoea in 50%. Febrile morbidity was seen in 8.3% cases. There were no complications of the procedure. The method was highly acceptable to the patients being non-invasive and allowing ambulation throughout. This method of elective mid-trimester abortion is an effective alternative to the other commonly used methods like extra-amniotic ethacridine lactate or intra-amniotic hypertonic saline instillation.

KEY WORDS: Carboprost, Mid-trimester abortion, PGE2


Elective termination of second trimester pregnancy is a commonly performed gynaecological procedure. Although several methods have been tried over the years with varying success [1, 2, 3, 4], the ideal method for induction of mid-trimester abortion has remained elusive, as indicated by the constant search for newer techniques. An ideal method should be non-invasive, improve the success rate, shorten the induction-abortion-interval (I-A-I), reduce the risk of complications and side effects and should have a high patient acceptability. Ever since prostaglandins have become available for clinical use, the techniques for mid-trimester abortion have centred around preparations of prostaglandins used by different routes [5, 6, 7, 8, 9].

The purpose of this study was to evaluate the efficacy of a combination of endocervical PGE2 gel and serial intramuscular injections of carboprost in bringing about mid-trimester abortion, where the former is intended to provide a salutary effect on the cervical compliance.

Material and Methods

This prospective observational study was carried out at the department of Obstetrics and Gynaecology, Military Hospital Bareilly from July 96 to Dec 98. 60 patients were referred to the department for mid-trimester MTP during this period. Gestational age at the time of presentation was confirmed clinically and sonologically. A thorough pre-operative preparation was done and informed consent was obtained. Patients were hospitalised in the evening. At about 2100 h, instillation of endocervical PGE2 gel (Dinoprostone 0.5 mg, ASTRA-IDL) was done using a Cuso's speculum. The nursing staff was instructed to administer analgesia (Inj pentazocine or tab ketorolac) on SOS basis. The next morning, at 0600 h, two tab/cap of loperamide, 1 mg and inj metaoclopramide, 10 mg, were administered intramuscularly to prevent gastrointestinal side effects of prostaglandins. These were repeated after 6 h, or earlier if required. From 0630 h onwards, serial intramuscular injections of carboprost, 250 μg, (15-methyl-prostaglandin-F2a, Prostodin, ASTRA-IDL) were administered at 2 1/2 h intervals till the abortion process was completed. Analgesia (Inj pentazocine 30 mg IM and inj phenergan 25 mg IM) was administered on SOS basis. Patients were allowed to move about during the procedure. On completion of abortion, products of conception were examined for completeness and check curettage was done as and when considered necessary. Those who failed to abort within 48 h were deemed as failures. The outcome parameters studied were: success rate, I-A-I, incidence of incomplete abortion, side effects, complications and acceptability of the procedure. The last was evaluated through a questionnaire. All data from the study were analysed and compared with other studies on mid-trimester MTP.


Of the 60 cases in this study, 56 were multiparae who were also candidates for sterilization. The commonest indication for abortion was unwanted pregnancy due to failure of contraception. (Table 1) In primigravidae, MTP was indicated for congenital malformations of the fetus or intra-uterine death. The maternal age ranged from 15-38 years with a mean of 27.6 years. The gestational age ranged from 15-22 weeks with a mean of 17 weeks (Table 2).

Indication for mid-trimester abortion
Gestational age at the time of abortion

All 60 cases aborted within 48 h making the procedure 100% successful. The mean I-A-I was 8.4h ± 0.8 h (Table 3). On an average four injections of carboprost were required till the completion of abortion. It was seen that, unlike in term labour, placental expulsion took longer than 2h from the expulsion of fetus in 32 (53.3%) cases. In 3 cases (5%) placenta was removed digitally and in 10 cases (16.6%) check curettage was performed on suspicion of retained placental bits. There were no cases of excessive vaginal bleeding, uterine rupture or cervical lacerations. There were no live births in this study. Gastrointestinal side effects were common. Nausea and vomiting occurred in 25 cases (42%) and diarrhoea in 30 cases (50%). Febrile morbidity was seen in 5 cases (8.3%) where more than six injections of carboprost were required (Table-4). The procedure was well received by the patients for three main reasons: it was short, noninvasive and allowed ambulation. The procedure was found to require less effort compared to other procedures where oxytocin infusion is made for a long time.

Induction abortion interval (IAI)
Side effects of the procedure


Success rate and I-A-I from various studies are compared with our results in Table-5. It is evident from this comparison that a combination of endocervical PGE2 gel and serial carboprost injections yields highest success rate and shortest I-A-I.

Comparison of results with other studies

In India, extra amniotic instillation of ethacridine lactate followed by oxytocin infusion is a commonly used method of mid-trimester MTP. The I-A-I by this method is 27 h [1]. The procedure is invasive and entails the risk of inciting placental bed bleeding which may necessitate a hysterotomy. Intra-amniotic instillation of hypertonic saline is another popular method. This procedure is also invasive and is occasionally associated with maternal deaths [2, 4].

In recent times prostaglandins have found favour with most obstetricians as abortifacients of choice. Different preparations have been tried by different routes.

In our study, we have taken advantage of the softening effect of endocervical PGE2 gel on the uterine cervix [10]. A compliant cervix readily dilates in response to carboprost induced uterine contractions. This permits a shorter abortion time and minimises the risk of cervical lacerations.

Vomiting and diarrhoea were common side effects in our study but the incidence was less than that reported by earlier workers [5, 7]. This decrease in gastrointestinal side effects is probably due to use of prophylactic pharmacotherapy in our series. We agree that patients questioned subsequent to the abortion underestimate these side effects.

Live births is another concern in prostaglandin abortions [11]. In our study we had no live births probably due to the lower gestational age at the time of presentation. Kajanoja et al [6] have expressed concern over cervical lacerations in prostaglandin induces abortions. None of our patients had cervical lacerations due to the softening effect of PGE2 gel.

To conclude, endocervical PGE2 gel for pre-induction cervical priming forms a valuable adjunct to serial carboprost injections in achieving mid-trimester MTP.

This combination is non-invasive, technically simple, has a high success rate and a short I-A-I. In addition, the procedure is free of complications and has high patient acceptability. Minor gastrointestinal side effects are common when prostaglandins are used but are not distressing.


1. Manabe Y. Artificial abortion at mid pregnancy by mechanical stimulation of the uterus. Am J Obstet Gynaecol. 1969;105:132–135. [PubMed]
2. Kerenyi TD, Mandelman N, Sherman D. Five hundred consecutive saline abortions. Am 3 Obstet Gynecol. 1973;116:593–598.
3. Burnett LS, King TM, Atienza MF. Intra-amniotic urea as a mid trimester abortifacient: Clinical results and serum and urinary changes. Am J Obstet Gynaecol. 1975;121:7–10. [PubMed]
4. Suthutvoravut S, Supachropongkul V, Bhiromswasdi S. Mid-trimester abortion by hypertonic saline instillation-experience at Ramathibodi Hospital. J Med Assoc Thai. 1983;66:176–180. [PubMed]
5. Wentz AC, Austin K, King TM. Abortifacient efficacy of intravaginal prostaglandin F2a. Am J Obstet Gynecol. 1973;115:27–32. [PubMed]
6. Kajanoja P, Jungner G, Seppala M. Prostaglandin induction of 424 mid-trimester abortions. Int J Obstet Gynecol. 1974;12:198–201.
7. Bolognese RJ, Corson SL. Prostaglandin E2 vaginal suppository as a mid-trimester abortifacient. Am J Obstet Gynecol. 1974;120:281–284. [PubMed]
8. Bygdeman M. Comparison of prostaglandins and hypertonic saline for termination of pregnancy. Obstet Gynecol. 1978;52:424–428. [PubMed]
9. Herabutya Y, Israngura N, Ayudthaya N. Mid-trimester abortion using prostaglandin E2 gel. Int J Obstet Gynecol. 1990;34:169–173. [PubMed]
10. Karim SMM. Action of prostaglandins in the pregnant woman. Ann NY Acad Sci. 1971;180:483–490. [PubMed]
11. Borgida AF, Rodis JF, Hanlos W, Craffey A. Second trimester abortion by intramuscular 15-methyl prostaglandin F2a or intravaginal prostaglandin E2 pessaries: A randomised trial. Obstet Gynaecol. 1995;85:697–700. [PubMed]
12. WHO Prostaglandin Task Force Intramuscular administration of 15-methyl-PGF2a for induction of abortion in the 10th to 20th week of pregnancy. Am J Obstet Gynecol. 1995;192:593–596.
13. WHO Prostaglandin Task Force Single extra-amniotic administration of 15-methyl-PGF2a in hyskon for termination of pregnancy in the 10th to 20th week of gestation: An international multicentric study. Am J Obstet Gynecol. 1977;129:597–600. [PubMed]

Articles from Medical Journal, Armed Forces India are provided here courtesy of Elsevier